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Abstract
Background: Despite extensive literature, little is known about the mechanisms underlying sex bias in autism
spectrum disorder (ASD). This study investigates the sex differences in ASD associated with neurofibromatosis
type 1, a single-gene model of syndromic autism.
Methods: We analysed data from n = 194 children aged 4–16 years with neurofibromatosis type 1. Sex differences
were evaluated across the Autism Diagnostic Interview-Revised (ADI-R), Autism Diagnostic Observation Schedule
(ADOS), verbal IQ, Social Responsiveness Scale (SRS) and Conners questionnaires.
Results: There was 2.68:1 male:female ratio in children meeting ASD criteria on the deep phenotyping measures.
On symptom profile, males with neurofibromatosis type 1 (NF1) + ASD were more impaired on reciprocal social
interaction and communication domains of the ADI-R but we found no differences on the restricted, repetitive
behaviours (RRBs) domain of the ADI-R and no differences on the social on the ADOS. NF1 ASD males and females
were comparable on verbal IQ, and the inattention/hyperactivity domains of the Conners questionnaire.
Conclusions: There is a significant male bias in the prevalence of ASD in NF1. The phenotypic profile of NF1 + ASD
cases includes greater social communication impairment in males. We discuss the implications of our findings and
the rationale for using NF1 as a model for investigating sex bias in idiopathic ASD.
Keywords: Neurofibromatosis type 1, Autism spectrum disorder, Sex bias, Syndromic autism
Background
Sex bias in the prevalence of autism spectrum disorders
(ASD) is a widely replicated finding, with a male prepon-
derance in a ratio of 4:1 (male:female) across the whole
autism spectrum [1, 2]. Recent studies suggest that a
number of methodological issues may influence this ra-
tio, including differences in ascertainment procedures,
interaction with intelligence quotient (IQ) and underrep-
resentation of females in research studies [3]. However,
despite such methodological limitations, a relative male
preponderance remains a stable observation across all
research studies. The male preponderance is not unique to
ASD but also seen other neurodevelopmental conditions
such as attention deficit hyperactivity disorder (ADHD),
dyslexia and developmental language disorders [4]. Study of
the mechanisms underlying these sex differences is import-
ant as it may help illuminate causal processes within these
early onset neurodevelopmental conditions.
In the context of idiopathic ASD, a number of theories
have been postulated to explain the apparent sex bias;
however, to date, no definitive evidence has emerged to
favour any particular one. The most prominent theory is
the ‘female protective effect’ (FPE), which suggests that
assumed female-specific biological or development fac-
tors confer a general protective effect so as to make the
effective ASD threshold higher for females [5]. This the-
ory predicts that females with ASD will show higher
levels of associated abnormalities compared to males [6].
This prediction is supported by the finding for instance
that ASD females show a higher mutational burden, ex-
cess deleterious autosomal copy number variations and
private single-nucleotide variations [7] as compared to
ASD males. A complementary theory postulates male-
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specific vulnerability or risk factors that lower a thresh-
old to meet ASD criteria. An example would be expos-
ure to foetal testosterone [8] or sex-related genetic
factors such as increased ASD risk associated with rare
variants genes on the X chromosome such as neurolo-
gins 3 and 4 [9], MeCP2 and Fragile X syndrome. At a
cognitive trait level, the ‘extreme male brain’ theory pro-
poses that ASD is an extreme manifestation of the normal
male brain, with the disorder resulting from exaggerated
putative psychological sex differences in empathising and
systemizing [10]. A different kind of explanation is that
the sex ratio in fact relates to a simple ascertainment bias,
resulting from inherent sex biases in the ASD diagnostic
criteria and instruments. This explanation maintains that
the descriptions of autism and norms established on diag-
nostic instruments are largely based on research carried
out in predominantly male populations [11]; and that
symptom exemplars specific to female presentations are
not, as a consequence, clearly emphasised in diagnostic in-
struments [12]. In support of this view, studies investi-
gating differences in behavioural profiles in males and
females with ASD suggest decreased levels of re-
stricted, repetitive behaviours in females with no con-
sistent findings in the social communication symptom
profile [11, 13]. The largest study to date using the
Simons Simplex Collection of n = 2418 ASD probands
(304 females, 2114 males) found that the females with
ASD had greater social communication impairment,
lower levels of restricted interests, weaker adaptive
skills, greater externalising problems and lower cogni-
tive abilities relative to the males [12]. Similarly, a
meta-analysis of 22 studies confirmed lower levels of
restricted and repetitive behaviours in females but
found no difference in social communication and
interaction [14].
A novel route to approach an understanding of the
mechanisms underlying sex bias in ASD may be through
the study of specific gene disorders causing autism,
where the identified causal genetic variant can be as-
sumed to carry a very large proportion of an individual’s
autism risk. For example, a study investigating microde-
letions of SHANK1 in a four-generation family found
that male carriers met the clinical criteria for ASD,
whereas female carriers with the same mutation showed
evidence of anxiety but not ASD [15]. Similarly, ASD as-
sociated with Down’s syndrome shows significantly re-
duced penetrance in females with the disorder [16]. In a
number of these specific gene disorders, considerably
more is known about the neurobiology and gene pheno-
type pathway than in idiopathic autism. Moreover,
animal models of syndromic autism can be leveraged to
study mechanisms underlying the sex differences.
A strong candidate disorder for this kind of specific
gene study is neurofibromatosis type 1 (NF1), a common
autosomal dominant single-gene disorder with an esti-
mated birth incidence of 1 in 2700 [17]. Population- and
clinical-based studies using gold standard diagnostic as-
certainment [18, 19] have demonstrated a prevalence of
about 25 % ASD in NF1. Phenotypically, ASD in NF1
shows overall similarity to idiopathic ASD with impair-
ments across the domains of social interaction and re-
stricted repetitive behaviours (RRBs) [20]. IQ is generally
in the normal range (mean full scale IQ of 80–90 [21, 22]
and presence of IQ <70 in just 4–8 %), and other
comorbidity commonly includes attention deficit hyper-
activity disorder. Estimate of male:female ratios of ASD in
NF1 have ranged between 1.7:1 and 3:1 [18, 19] but this
has not, until now, been studied in detail. A recent study
using Nf1 mouse models demonstrated that learning/
memory deficits are only observed in male animals [23].
There is considerable inter- and intra-familial variability in
the physical phenotypic expression in NF1 [24]. The only
sex bias in the physical phenotype reported to date is the
elevated risk for optic gliomas in females as compared to
males with NF1 [25].
The aim of the present study is to examine sex differ-
ences in the behavioural and cognitive phenotype in
children with NF1. Based on the findings of previous stud-
ies, we investigate whether females with NF1 + ASD show
greater symptom severity in the social communication
and interaction domain and lower repetitive behaviour
symptom levels and cognitive ability when compared to
males with NF1 + ASD.
Methods
Participants
Data was analysed on children with NF1 and ASD
aged 4–18 , drawn from two databases: (1) cohort 1: a
genetic registry whole population cohort of children
with NF1 aged 4–18 years living in the north of Eng-
land. A two-stage procedure of Social Responsiveness
Scale (SRS) screening followed by gold-standard ASD
assessment using Autism Diagnostic Interview-Revised
(ADI-R) and Autism Diagnostic Observation Schedule
(ADOS) was used. The NICHD-CPEA (National Insti-
tute of Child Health and Human Development Collab-
orative Programs of Excellence in Autism; see
procedures for description) criteria were used to iden-
tify children with ASD [18]. This study was approved
by Greater Manchester South ethics committee (REC
reference 11/NW/0838). Data on the SRS was available
for n = 110 and in-depth phenotyping data from n =
46/109 of this database.
(2) Cohort 2: a separate cohort drawn from NF registers
at regional genetic centres (Manchester, Leeds, Newcastle,
Warrington, Wirral, Alderhey, Sheffield and Edinburgh), as
part of an ongoing randomised controlled trial of NF1 +
ASD treatment (SimvAstatin in Neurofibromatosis Type 1
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Autism (SANTA; EudraCT number: 2012-005742-38, ap-
proval granted by Greater Manchester Central Ethics com-
mittee, REC reference 13/NW/0111). Here, participant
families were recruited via advertisements in NF charities
newsletters and social media, as well as clinical referral.
Signed informed consent was obtained from all parents and
assent from all minor participants. Screen positive children
on SRS (T > 60) were given in-depth assessment with ADI-
R and ADOS. Data on the SRS were available for n = 85
and in-depth phenotyping data were available for n = 50/85
of this database.
There were significant differences between the NF1
cohorts from the two databases in age (mean age in co-
hort 1 = 9.87, SD 3.31 and in cohort 2 = 7.45, SD 1.82)
and SRS T scores (SRS T = 63.09, SD 14.10 in cohort 1
and SRS T = 78.28, SD 14.52 in cohort 2, T = −7.35, p <
0.001). Participants were recruited and assessed for the
original studies between October 2009 and March 2015.
Measures
SRS 1 and SRS 2
The SRS is a 65-item measure rated on a 4-point Likert
scale (1 = never true to 4 = almost always true), which in-
cludes five dimensions—social awareness, social cogni-
tion, reciprocal social interaction, social motivation and
autistic mannerisms. SRS total scores of 76T or higher
are in the severe range and are associated with a clinical
diagnosis of ASD. It has a sensitivity of 0.85 and specifi-
city of 0.75 for identifying independent consensus expert
clinician diagnosis of ASD [26]. Total scores of between
66T and 75T indicate moderately range deficiencies, 60T
and 65T indicate mild range deficiencies in reciprocal
social behaviour and scores below 59 are considered as
being in the normal range. The total T scores were com-
puted from the raw scores according to the algorithms
available in the SRS-2 manual [27].
ADI-R
The ADI-R is a semi-structured, standardised diagnostic
interview administered to the caregiver. It consists of 95
items, each of which are coded for current and past be-
haviour (at age 4–5 years) according to the examiner’s
judgement of the presence/absence or the extent of a
given behaviour using a scale of 0 (behaviour not
present), 1 (behaviour present but not sufficiently severe
or frequent to meet criteria for 2), 2 (definite abnormal-
ity) or 3 (definite abnormality and marked in severity).
The diagnostic algorithm consists of individual behav-
iour items that have shown good discrimination between
groups of children with and without autism. It is based
on the most abnormal 4–5-year/ever codes divided into
three domains: social interaction, communication and
restricted repetitive behaviours [28]. Further, each do-
main includes four subscales (see Table 2) each, and
each subscale includes the number of individual items.
A classification of ASD is given when scores in all the
three domains exceed the specified cutoffs which is 10 is
social interaction domain, 8 in communication and 3 for
restricted, repetitive behaviours.
ADOS
The ADOS is a standardised interviewer-rated meas-
ure for child observation and assessment of skills in
communication, social interaction, quality of play and
imagination. It is organised into four modules based
on the child’s expressive language level. It consists of
standardised activities that allow the examiner to ob-
serve occurrence of behaviours that have been identi-
fied as being important to the diagnosis of ASD.
Scores on individual items range from 0 (no evident
abnormality) to 3 (marked abnormality). The ADOS-2
diagnostic algorithm was used to score the observa-
tions. This algorithm has two domains of ‘social affect’
and ‘restricted repetitive behaviours’ consistent with
DSM-5 [29]. An overall total of 7 or higher is classi-
fied as meeting criteria for ASD.
Conners 3 and Conners Parent Rating Scale-Revised
Conners-3 and CPRS-R short form was used as a meas-
ure for ADHD symptoms [30, 31]. It consists of 27 items
each rated on a 4-point Likert scale (0 = no true at all to
3 = very much true) in four subscales: oppositional,
hyperactivity, cognitive problems and ADHD index.
Wechsler Abbreviated Scale of Intelligence (WASI) [32]
The vocabulary and similarity sub-tests of the WASI
were used in children over 6 years of age as a measure
of intellectual ability.
Procedure
Medical notes of all patients were reviewed to confirm
the diagnosis of NF1 using the National Institutes of
Health (NIH) diagnostic criteria [33]. The SRS and Con-
ners questionnaires were completed by the parent or
primary caregiver. Detailed phenotyping was carried out
using examiner rated ADI-R for parent interviews and
ADOS + WASI (verbal sub-scale) for child observation
and assessment. The ADI-R assessments were audio-
recorded, and the ADOS assessments were video-
recorded. All measures were administered by trained
researchers and scored during or immediately after ad-
ministration. Participants were given the research diag-
nosis of ASD if they met the cutoff criteria on all the
three domains of the ADI-R and the overall ASD cutoff
criteria on the ADOS.
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Statistical analysis
Data were analysed using SPSS version 17. We com-
pared NF1 males with NF1 females in terms of demo-
graphics and clinical characteristics using two-sample t
tests for continuous data and χ2 tests for categorical data
(Table 1). In the subset who had received in-depth
clinical assessment, we compared males and females in
terms of means and standard deviations on ADI-R sub-
scales, ADOS, Conners, SRS, and verbal IQ using two-
sample t tests (Table 2). Finally, the ASD males were
compared with ASD females on ADI-R subscales,
ADOS, Conners, SRS and verbal IQ using the two-
sample t test; p values and the standardised mean differ-
ences are reported (Table 3). The critical p values for
significance were Bonferroni adjusted.
Results
Demographic and clinical characteristics of the sample
SRS data were available for n = 194 children with NF1,
of whom n = 101 (53.09 %) were male. The mean age of
the sample was 8.8 years (SD 2.0, range 4.0–16.5). The
pattern of inheritance was familial in n = 93, de novo in
n = 75, and unknown in n = 26 cases. There were no
sex differences in age, familial pattern of inheritance
and in having a statement of special educational needs
(see Table 1).
On the SRS questionnaire, males had significantly
higher raw scores than females on all of sub-domains.
The proportion of males with T scores ≤59, 60 to 65, 66
to 75 and ≥76 were 27.2, 12.6, 14.6 and 45.6 %, respect-
ively. The proportion of females with T scores ≤59, 60
to 65, 66 to 75 and ≥76 were 37.4, 14.3, 15.4 and
33.0 %, respectively (See Fig. 1).
Sex comparison on the detailed phenotyping measures
In-depth phenotyping data were available for n = 54
males and n = 42 females (total n = 96, 49.5 % of the total
sample). There were no differences between groups with
and without in-depth phenotyping data in terms of age
(8.6 (2.6) versus 9.1 (3.4), t = −1.12, p = 0.223) or sex (χ2 =
0.18, p = 0.667) but the SRS T scores were higher in the
group with the in-depth phenotyping data (77.2 (13.3) ver-
sus 62.2 (15.3), t = 7.16, p < 0.000) (Table 2).
On the ADI-R, significant sex differences were ob-
served on (i) three sub-scales in the reciprocal social
interaction domain failure to use non-verbal behaviours
to regulate social interaction, lack of shared enjoyment
and lack of socio-emotional reciprocity, (ii) two sub-
scales in communication domain failure to sustain
conversational interchange and stereotype speech and
(iii) preoccupation/circumscribed patterns of interest
sub-scale of the restricted, repetitive behaviours domain.
Males were significantly more impaired than females on
the ADOS Social Affect domain and had significantly
higher ADOS total scores. There were no statistically
significant sex differences on verbal IQ and Conners
inattention/hyperactivity sub-scales.
Sex differences on the sample that met the ASD cutoff
criteria on the ADI-R and ADOS
Of the children with in-depth phenotyping data, the
ASD cutoff criteria was met by 57.4 % (31/54) males and
21.4 % females (9/42) (χ2 = 12.58, p < 0.001). The mean
age of ASD males was 7.96 (SD 1.7) and females 8.61
(SD 3.27) (t = −0.81, p = 0.422).
Table 3 shows the detailed scores on the ADI-R sub-
scales, Connors, SRS and verbal IQ amongst males and
Table 1 Demographics and SRS treatment scales of the total sample of n = 194 children with NF1
Males (n = 103) Females (n = 91) Test statistic p value*
Age, mean (SD) 8.6 (2.9) 9.2 (3.1) T = −1.35 0.193
Familial inheritance, na 48 45 χ2 = 0.72 0.698
Educational statement, nb 17 18 χ2 = 0.11 0.744
SRS (raw scores), mean (SD)
Social Communication and Interaction (SCI) domain 71.57 (32.91) 55.77 (29.79) T = 3.49 0.001
Social awareness 11.60 (4.81) 9.30 (4.36) T = 3.48 0.001
Social cognition 17.02 (8.98) 12.98 (7.98) T = 3.29 0.001
Social communication 29.65 (15.06) 22.43 (13.14) T = 3.53 0.001
Social motivation 13.30 (6.94) 11.07 (7.05) T = 2.22 0.001
Restrictive and repetitive behaviours domain 17.93 (8.67) 13.56 (8.56) T = 3.52 0.001
SRS total raw score 89.50 (40.74) 69.33 (37.48) T = 3.57 <0.001
*Significant if p < 0.005
aDisease inheritance data available for n = 88 males and n = 80 females
bEducational statement data available for n = 77 males and n = 74 females
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females with ASD. The only significant differences were
observed on two subscales of the ADI-R failure to use
non-verbal behaviours to regulate social interaction and
failure to initiate conversational interchange on the so-
cial communication domain. No sex differences were ob-
served on the restricted and repetitive domain of the
ADI-R. Similarly, there were no sex differences on the
ADOS social affect, repetitive behaviour or the ADOS
total scores. There were no significant differences on the
Conners inattention/ hyperactivity domains, verbal IQ or
the SRS total scores. The standardised mean differences
between the groups is also reported which suggest large
effect sizes for the reciprocal social interaction and com-
munication domains of the ADI-R (other than failure to
develop peer relationships A2 and stereotyped/idiosyn-
cratic speech B3 sub-scales).
Discussion
To our knowledge, this is the first study investigating
sex differences in ASD using a syndromic model of
autism. We found a significant sex bias in ASD preva-
lence at a ratio of 2.68:1 males:females. This latter find-
ing is similar to the rates reported in the idiopathic ASD
literature in children with average or below average IQ
and is consistent with findings reported by Plasschaert et
al. who found similar rates of sex bias in a clinic-
ascertained NF1 + ASD sample (n = 27) [19]. The groups
in our study were well matched on co-morbid ADHD
symptomatology and verbal IQ. In the context of other
specific gene syndromic autism, our findings of a male
bias in NF1-ASD are similar to results in SHANK1 [15]
and Down’s syndrome [16]; however, this sex disparity is
not seen in genetic disorders associated with high levels of
intellectual impairment, such as tuberous sclerosis [34]
and Cornelia de Lange syndrome [35].
Regarding the phenotypic profile, we found that NF1
males showed overall greater social communication
impairments on the SRS, ADI-R and ADOS (Tables 1
and 2). However, no statistically significant differences
were observed between males and females on Conners
inattention/hyperactivity domains and on verbal IQ.
Given the small samples sizes of the NF1 + ASD sub-
group (Table 3), we report the standardised mean
differences between ASD males and females. ASD
males are more impaired in the social interaction and
communication domains. There are no significant sex
Table 2 Characteristics of NF1 males versus NF1 females on ADI-R subscales, Conners, SRS and verbal IQ
Males (n = 54) Females (n = 42) t test P value*
Mean (SD)
ADI-R: reciprocal social interaction (A)
Failure to use non-verbal behaviours to regulate social interaction (A1) 3.61 (1.74) 1.74 (1.45) 4.98 <0.001
Failure to develop peer relationships (A2) 5.19 (2.53) 3.57 (2.56) 3.08 0.003
Lack of shared enjoyment (A3) 3.30 (1.75) 1.71 (1.67) 4.47 <0.001
Lack of socio-emotional reciprocity (A4) 4.63 (2.26) 2.76 (2.09) 4.15 <0.001
ADI-R: communication (B)
Lack/delay in spoken language and failure to compensate through gestures (B1) 2.85 (2.56) 1.57 (2.11) 2.62 0.01
Lack of varied make-believe play (B4) 3.96 (2.06) 2.06 (2.28) 2.92 0.004
Relative failure to initiate/sustain conversational interchange (B2) 2.83 (1.40) 1.45 (1.23) 5.05 <0.001
Stereotyped, repetitive or idiosyncratic speech (B3) 3.33 (1.49) 2.10 (1.96) 3.51 0.001
ADI-R: restricted, repetitive and stereotyped patterns of behaviour (C)
Encompassing preoccupation or circumscribed pattern of interest (C1) 1.57 (1.34) 0.66 (0.96) 3.70 <0.001
Apparently compulsive adherence to non-functional routines or rituals (C2) 1.44 (1.29) 1.19 (1.42) 0.91 0.364
Stereotyped and repetitive motor mannerisms (C3) 0.57 (0.82) 0.52 (0.80) 0.30 0.764
Preoccupation with parts of objects or non-functional elements of material (C4) 1.20 (0.88) 0.74 (0.73) 2.77 0.007
ADOS-SA total 8.11 (4.42) 4.52 (4.03) 4.10 <0.001
ADOS-RRB total 1.41 (1.54) 0.69 (1.33) 2.40 0.018
ADOS overall total (SA + RRB) 9.48 (5.28) 5.50 (4.46) 3.92 <0.001
Conners-inattentiona 67.97 (13.64) 68.03 (14.41) −0.02 0.981
Conners-hyperactivitya 67.19 (15.53) 66.82 (16.64) 0.14 0.890
SRS T scores 72.17 (16.09) 67.00 (15.81) 2.25 0.025
Verbal IQ 89.98 (14.19) 95.38 (16.36) −1.67 0.099
aConners data available for n = 78 males and n = 67 females. *Significant if p < 0.002
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differences in the NF1 + ASD sample on the ADOS
total and SRS T scores, nor in ADHD symptomatology
or verbal IQ. These findings are therefore in contrast
to those reported in the idiopathic ASD literature, in
which ASD females have been reported to have more
social communication impairment, lower levels of
repetitive behaviours, greater externalising problems
and lower cognitive abilities as compared to ASD
males [12]. However, these results are limited by small
sample sizes of NF1 females (n = 9, Table 3) and need
to be replicated in larger samples.
How might the results of sex bias in NF1 ASD be ex-
plained? The NF1 gene encodes for protein neurofibro-
min, which in turn regulates different downstream
signalling effectors such as cAMP, dopamine and Ras/
mammalian target of rapamycin (mTOR). Using Nf1
genetically engineered animal model, a recent study has
demonstrated that increased glioma risk in females with
Fig. 1 SRS total T scores in males and females in the whole
sample n = 194





t test P value* Standardised mean
difference (Cohen’s d)
Est. (95 % CI)
Mean (SD)
ADI-R: reciprocal social interaction (A)
Failure to use non-verbal behaviours to regulate
social interaction (A1)
4.55 (1.54) 2.44 (1.01) 3.83 <0.001 1.451 (0.640, 2.262)
Failure to develop peer relationships (A2) 6.63 (1.56) 6.0 (1.12) 1.13 0.267 0.428 (−0.323, 1.179)
Lack of shared enjoyment (A3) 4.16 (1.32) 2.67 (1.87) 2.72 0.010 1.029 (0.252, 1.806)
Lack of socio-emotional reciprocity (A4) 5.74 (1.75) 4.33 (2.40) 1.94 0.058 0.739 (−0.021, 1.500)
ADI-R: communication (B)
Lack/delay in spoken language and failure to compensate
through gestures (B1)
4.32 (2.29) 2.33 (2.29) 2.29 0.027 0.870 (0.102, 1.637)
Lack of varied make-believe play (B4) 5.13 (1.28) 4.11 (1.17) 2.13 0.039 0.808 (0.044, 1.572)
Relative failure to initiate/sustain conversational interchange (B2) 3.58 (0.72) 2.33 (1.50) 3.51 0.001 1.327 (0.528, 2.127)
Stereotyped, repetitive or idiosyncratic speech (B3) 3.68 (1.56) 3.67 (2.45) 0.02 0.987 0.006 (−0.736, 0.748)
ADI-R: restricted, repetitive and stereotyped patterns of behaviour (C)
Encompassing preoccupation or circumscribed pattern of interest (C1) 2.23 (1.33) 1.38 (1.51) 1.57 0.125 0.622 (−0.168, 1.412)
Apparently compulsive adherence to non-functional routines
or rituals (C2)
1.87 (1.15) 2.67 (1.23) −1.81 0.079 −0.684 (−1.441, 0.074)
Stereotyped and repetitive motor mannerisms (C3) 0.71 (0.90) 1.11 (1.05) −1.13 0.264 −0.429 (−1.177, 0.319)
Preoccupation with parts of objects or non-functional elements
of material (C4)
1.61 (0.76) 1.11 (0.78) 1.73 0.091 0.656 (−0.101, 1.412)
ADOS-SA total 10.45 (3.44) 8.33 (2.23) 1.73 0.091 0.656 (−0.100, 1.413)
ADOS-RRB total 2.16 (1.59) 1.67 (2.18) 0.75 0.456 0.285 (−0.460, 1.030)
ADOS Overall total (SA + RRB) 12.61 (3.96) 10.0 (3.24) 1.81 0.079 0.683 (−0.074, 1.441)
Conners-inattention 76.03 (11.17) 80.0 (16.04) −0.78 0.439 −0.327 (−1.151, 0.496)
Conners-hyperactivity 75.19 (12.26) 77.0 (22.20) −0.30 0.766 −0.125 (−0.946, 0.695)
SRS total T scores 84.35 (10.12) 85.33 (9.49) −0.259 0.797 −0.098 (−0.840, 0.644)
Verbal IQ 88.50 (12.95) 90.38 (10.96) −0.370 0.714 −0.149 (−0.943, 0.644)
*Significant if p < 0.002
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Nf1 is linked to a modifier gene and sexually dimorphic
cAMP signalling [25]. However, the molecular mecha-
nisms for sex-specific modifiers in NF1 ASD are poorly
understood. One plausible hypothesis could be the role
of sex hormones in mediating differential sensitivity to
downstream effectors. Another hypothesis may be that
sex interacts with germline NF1 mutation through
epigenetic mechanisms to produce changes in gene ex-
pression [23]. Altogether, the data is compatible with the
female protective effect, although the exact mechanisms
for this are unclear. Simple measurement ascertainment
bias is not supported by our data, since, between sex-
specific groups that are otherwise balanced for IQ and
co-morbidity, the male bias is apparent on the parent-
rated dimensional SRS measure as well as researcher
rated in-depth phenotyping measures. Further, prospect-
ive studies of sex-specific developmental trajectories in
NF1 could help clarify how the gene environment inter-
action may contribute to the emergence of sex differ-
ences in NF1 ASD. It would also be useful to better
understand the sex differences in the ASD phenotype in
other models of syndromic autism.
These findings should be interpreted in light of the
study’s limitations. Our study samples were drawn from
two separate cohorts with significant differences in age
and SRS T scores; however, we think that it is unlikely
that this influences out interpretations of the results.
The sample from cohort 2 was part of a RCT using
Simvastatin treatment in children with NF1 ASD; partic-
ipants were actively recruited in the RCT on the basis of
ASD symptomatology on the SRS. There is no evidence
however that the different origin of the included cohort
influenced the analysis findings. Secondly, we acknow-
ledge the relatively small sample size of the NF1 + ASD
females, thus limiting the conclusions that can be drawn
from the data presented in Table 3. Nonetheless, this is a
novel approach to the investigation of sex differences in
ASD in a single-gene syndromic model, which gives
strength to our interpretation.
Conclusions
The present study suggests a significant male bias in the
incidence of NF1 + ASD. The phenotypic profile of NF1 +
ASD cases includes greater social communication impair-
ment in males but comparable levels of RRBs, ADHD
symptomatology and cognitive abilities. Our data support
the possibility of sex-specific modifiers in NF1 which con-
fer a female protective effect to ASD in neurodevelopment
and suggests that NF1 is a strong candidate model for in-
vestigation of sex differences in ASD.
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